Why is Suven Life Scie. falling/rising?

As of 21-Jul, Suven Life Sciences Ltd is currently priced at 288.90, reflecting a slight increase of 0.4 (0.14%). The stock has shown a strong performance over the past month, with a return of +27.30%, significantly outperforming the Sensex, which declined by -0.25%. Despite this positive trend, the stock has faced challenges, including a recent trend reversal after three consecutive days of decline. Additionally, the stock is currently 4.88% away from its 52-week high of Rs 303. However, the company has reported operating losses and negative results for the last three consecutive quarters, which raises concerns about its long-term fundamental strength. The negative growth in net sales and operating profit over the past five years, combined with a weak ability to service debt, has contributed to a perception of risk among investors.
In the broader market context, Suven Life Sciences Ltd has outperformed the benchmark indices over various time frames, including a remarkable +124.56% year-to-date return compared to the Sensex's +5.20%. However, the stock's recent performance has been marred by falling investor participation, with a significant drop in delivery volume and a decrease in institutional investor stakes. This decline in participation may indicate a lack of confidence among more sophisticated investors regarding the company's fundamentals. While the stock has shown strong returns in the long term, the combination of operational challenges and reduced investor interest suggests a complex outlook for its future performance.